Natural Product: NPC506343

Natural Product IDNPC506343
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
5,6,7,3',4'-pentahydroxyisoflavone
IUPAC Name 3-(3,4-dihydroxyphenyl)-5,6,7-trihydroxy-chromen-4-one
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey BIDDAFIPYBBDES-UHFFFAOYSA-N
Standard InCHI InChI=1S/C15H10O7/c16-8-2-1-6(3-9(8)17)7-5-22-11-4-10(18)14(20)15(21)12(11)13(7)19/h1-5,16-18,20-21H
SMILES O=C1C(C2=CC=C(O)C(O)=C2)=COC2=CC(O)=C(O)C(O)=C12

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   302.04 Volume:   282.767
?
Van der Waals volume.
Dense:   1.068 LogP:   1.085
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   1.151
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -3.324
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   1.0 Rigid Bonds:   18.0
TPSA:   131.36
?
Topological Polar Surface Area.
H-Bond Acceptor:   7.0
H-Bond Donor:   5.0 Rings:   3.0
Heavy Atoms:   7.0

MedChem Properties

QED Drug-Likeness Score:   0.434 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   2.613 Fsp3:   0.0
MCE-18:   19.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Rejected
Golden Triangle Rule:   Rejected BMS Rule:   1
Chelating Alert:   1 PAINS Alert:   1
Colloidal aggregators:   0.873 Fluc inhibitor:   0.495
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.939
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.303
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.705 Promiscuous compounds:   0.899

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.262 MDCK Permeability:   -4.798
Pgp-inhibitor:   0.0 Pgp-substrate:   0.024
PAMPA:   0.904
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.1
20% Bioavailability (F20%):   0.987 30% Bioavailability (F30%):   0.996
50% Bioavailability (F50%):   0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.007 MRP1:   0.853
Plasma Protein Binding (PPB):   92.121% Volume Distribution (VD):   -0.55
Fu: 7.06%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.889
OATP1B3 inhibitor:   0.915 BCRP inhibitor:   0.953
BSEP inhibitor:   0.01

ADMET: Metabolism

CYP1A2-inhibitor:   0.048 CYP1A2-substrate:   0.001
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.012
CYP2C9-inhibitor:   0.08 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.353 CYP2D6-substrate:   0.948
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   0.184
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.997
HLM stability:   0.447
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  14.746 Half-life (T1/2):  1.766

ADMET: Toxicity

hERG Blockers:  0.099 hERG Blockers (10um):  0.795
Human Hepatotoxicity (H-HT):  0.383 Drug-induced Liver Injury (DILI):  0.843
AMES Toxicity:  0.65 Rat Oral Acute Toxicity:  0.471
Maximum Recommended Daily Dose:  0.794 Skin Sensitization:  0.997
Carcinogencity:  0.443 Eye Corrosion:  0.064
Eye Irritation:  0.991 Respiratory Toxicity:  0.456
Drug-induced Neurotoxicity:  0.004 Ototoxicity:  0.795
Hematotoxicity:  0.022 Drug-induced Nephrotoxicity:  0.014
Genotoxicity:  0.974 RPMI-8226 Immunitoxicity:  0.006
A549 Cytotoxicity:  0.958 Hek293 Cytotoxicity:  0.246
BCF:   1.027
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.743
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.532
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.266
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO1565 Lepidium sativum Species Brassicaceae Eukaryota n.a. n.a. n.a. DOI[10.1023/A:1002708427984]
NPO1565 Lepidium sativum Species Brassicaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO1565 Lepidium sativum Species Brassicaceae Eukaryota n.a. n.a. Database[FooDB]
NPO1565 Lepidium sativum Species Brassicaceae Eukaryota Leaf n.a. n.a. Database[FooDB]
NPO1565 Lepidium sativum Species Brassicaceae Eukaryota Oil n.a. n.a. Database[FooDB]
NPO1565 Lepidium sativum Species Brassicaceae Eukaryota Plant n.a. n.a. Database[FooDB]
NPO1565 Lepidium sativum Species Brassicaceae Eukaryota Seed n.a. n.a. Database[FooDB]
NPO1565 Lepidium sativum Species Brassicaceae Eukaryota Leaves n.a. Database[FooDB]
NPO1565 Lepidium sativum Species Brassicaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO1565 Lepidium sativum Species Brassicaceae Eukaryota n.a. n.a. n.a. Database[TCMID]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC506343 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.7143 Intermediate Similarity NPC38065
0.6604 Remote Similarity NPC245382
0.6275 Remote Similarity NPC242893
0.6102 Remote Similarity NPC482730
0.5962 Remote Similarity NPC324929
0.5932 Remote Similarity NPC20472
0.5769 Remote Similarity NPC39426
0.5577 Remote Similarity NPC188074
0.5472 Remote Similarity NPC218490
0.5283 Remote Similarity NPC193792
0.5263 Remote Similarity NPC269451
0.5185 Remote Similarity NPC608554
0.5085 Remote Similarity NPC209487

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC506343 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.5769 Remote Similarity NPD1510 Phase 2

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data